STOCK TITAN

[Form 4] MILESTONE SCIENTIFIC INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Milestone Scientific (MLSS) reported insider stock sales. On 10/20/2025, the filer sold 24,034 shares of common stock at $0.4527, leaving 9,131,192 shares beneficially owned directly. On 10/21/2025, the filer sold an additional 40,000 shares at $0.4398, with 9,091,192 shares directly owned afterward.

The form was filed by one reporting person. The signature block shows /S/ Dr. Pedro Palau, Liquidator.

Milestone Scientific (MLSS) ha riportato vendite di azioni da parte di insider. Il 20/10/2025, il dichiarante ha venduto 24.034 azioni ordinarie a 0,4527 dollari, rimanendo direttamente proprietario di 9.131.192 azioni.

Il 21/10/2025, il dichiarante ha venduto ulteriori 40.000 azioni a 0,4398 dollari, con 9.091.192 azioni possedute direttamente dopo.

Il modulo è stato presentato da una persona dichiarante. Il blocco di firma mostra /S/ Dr. Pedro Palau, Liquidatore.

Milestone Scientific (MLSS) reportó ventas de acciones por parte de insiders. El 20/10/2025, el informante vendió 24.034 acciones ordinarias a $0,4527, quedando directamente poseyendo 9.131.192 acciones.

El 21/10/2025, el informante vendió adicionalmente 40.000 acciones a $0,4398, con 9.091.192 acciones directamente en propiedad después.

El formulario fue presentado por una persona reportante. El bloque de firma muestra /S/ Dr. Pedro Palau, Liquidador.

Milestone Scientific (MLSS)는 내부자 주식 매도를 보고했다. 2025-10-20에, 보고자는 24,034주의 보통주를 $0.4527에 매도하여 직접 보유 주식이 9,131,192주 남아 있다. 2025-10-21에, 보고자는 추가로 40,000주$0.4398에 매도했으며 그 후 9,091,192주를 직접 소유했다.

양식은 한 명의 보고자에 의해 제출되었다. 서명란에는 /S/ Dr. Pedro Palau, 청산인이 표시되어 있다.

Milestone Scientific (MLSS) a rapporté des ventes d'actions par des initiés. Le 20/10/2025, le déposant a vendu 24 034 actions ordinaires à $0,4527, restant directement propriétaire de 9 131 192 actions. Le 21/10/2025, le déposant a vendu des 40 000 actions supplémentaires à $0,4398, avec 9 091 192 actions directement détenues ensuite.

Le formulaire a été déposé par une personne déclarante. Le bloc de signature affiche /S/ Dr. Pedro Palau, Liquidateur.

Milestone Scientific (MLSS) meldete Insider-Verkäufe. Am 20.10.2025 verkaufte der Anmelder 24.034 Aktien Stammaktien zu $0,4527, wodurch direkt 9.131.192 Aktien als vorteilhaft gehalten blieben. Am 21.10.2025 verkaufte der Anmelder zusätzlich 40.000 Aktien zu $0,4398, danach direkt 9.091.192 Aktien gehalten.

Das Formular wurde von einer meldenden Person eingereicht. Im Unterschriftsblock steht /S/ Dr. Pedro Palau, Verwalter.

Milestone Scientific (MLSS) أبلغ عن مبيعات أسهم من insiders. في 20/10/2025، بايع المصرح بـ 24,034 سهمًا من الأسهم العادية بسعر $0.4527، مع الاحتفاظ مباشرةً بـ 9,131,192 سهمًا مملوكة. في 21/10/2025، باع المصرح مزيدًا من 40,000 سهم بسعر $0.4398، ليصبح هناك 9,091,192 سهمًا مملوكًا مباشرةً بعد ذلك.

تم تقديم النموذج من قبل شخص مُبلغ. يبرز كتلة التوقيع /S/ Dr. Pedro Palau, Liquidator.

Milestone Scientific (MLSS) 报告了内幕人士股票交易。于2025/10/20,该申报人以$0.4527价格出售了24,034 股普通股,直接持有9,131,192 股受益所有权。于2025/10/21,该申报人又出售了40,000 股,价格为$0.4398,之后直接持有9,091,192 股

该表格由一名申报人提交。签名块显示/S/ Dr. Pedro Palau, Liquidator

Positive
  • None.
Negative
  • None.

Milestone Scientific (MLSS) ha riportato vendite di azioni da parte di insider. Il 20/10/2025, il dichiarante ha venduto 24.034 azioni ordinarie a 0,4527 dollari, rimanendo direttamente proprietario di 9.131.192 azioni.

Il 21/10/2025, il dichiarante ha venduto ulteriori 40.000 azioni a 0,4398 dollari, con 9.091.192 azioni possedute direttamente dopo.

Il modulo è stato presentato da una persona dichiarante. Il blocco di firma mostra /S/ Dr. Pedro Palau, Liquidatore.

Milestone Scientific (MLSS) reportó ventas de acciones por parte de insiders. El 20/10/2025, el informante vendió 24.034 acciones ordinarias a $0,4527, quedando directamente poseyendo 9.131.192 acciones.

El 21/10/2025, el informante vendió adicionalmente 40.000 acciones a $0,4398, con 9.091.192 acciones directamente en propiedad después.

El formulario fue presentado por una persona reportante. El bloque de firma muestra /S/ Dr. Pedro Palau, Liquidador.

Milestone Scientific (MLSS)는 내부자 주식 매도를 보고했다. 2025-10-20에, 보고자는 24,034주의 보통주를 $0.4527에 매도하여 직접 보유 주식이 9,131,192주 남아 있다. 2025-10-21에, 보고자는 추가로 40,000주$0.4398에 매도했으며 그 후 9,091,192주를 직접 소유했다.

양식은 한 명의 보고자에 의해 제출되었다. 서명란에는 /S/ Dr. Pedro Palau, 청산인이 표시되어 있다.

Milestone Scientific (MLSS) a rapporté des ventes d'actions par des initiés. Le 20/10/2025, le déposant a vendu 24 034 actions ordinaires à $0,4527, restant directement propriétaire de 9 131 192 actions. Le 21/10/2025, le déposant a vendu des 40 000 actions supplémentaires à $0,4398, avec 9 091 192 actions directement détenues ensuite.

Le formulaire a été déposé par une personne déclarante. Le bloc de signature affiche /S/ Dr. Pedro Palau, Liquidateur.

Milestone Scientific (MLSS) meldete Insider-Verkäufe. Am 20.10.2025 verkaufte der Anmelder 24.034 Aktien Stammaktien zu $0,4527, wodurch direkt 9.131.192 Aktien als vorteilhaft gehalten blieben. Am 21.10.2025 verkaufte der Anmelder zusätzlich 40.000 Aktien zu $0,4398, danach direkt 9.091.192 Aktien gehalten.

Das Formular wurde von einer meldenden Person eingereicht. Im Unterschriftsblock steht /S/ Dr. Pedro Palau, Verwalter.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BP4 S.r.l.

(Last) (First) (Middle)
CORSO VENEZIA 44

(Street)
MILAN, L6 20121

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MILESTONE SCIENTIFIC INC. [ MLSS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, Par Value $0.001 10/20/2025 S 24,034 D $0.4527 9,131,192 D
Common Stock, Par Value $0.001 10/21/2025 S 40,000 D $0.4398 9,091,192 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/S/ Dr. Pedro Palau, Liquidator 10/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did MLSS report?

The filer reported sales of 24,034 shares at $0.4527 on 10/20/2025 and 40,000 shares at $0.4398 on 10/21/2025.

How many MLSS shares did the filer hold after the transactions?

After the 10/20/2025 sale, 9,131,192 shares were directly owned; after the 10/21/2025 sale, 9,091,192 shares were directly owned.

Were the MLSS transactions under a Rule 10b5-1 plan?

The form includes the Rule 10b5-1 checkbox language, but no selection is indicated in the provided excerpt.

What security was involved in the MLSS insider trades?

The transactions involved Common Stock, par value $0.001.

How many reporting persons filed the MLSS Form 4?

It states Form filed by One Reporting Person.

Who signed the MLSS Form 4?

The signature line reads /S/ Dr. Pedro Palau, Liquidator with a date of 10/23/2025.
Milestone Scient

NYSE:MLSS

MLSS Rankings

MLSS Latest News

MLSS Latest SEC Filings

MLSS Stock Data

34.99M
61.85M
21.42%
5.95%
0.24%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
LIVINGSTON